John Dawber, Corporate Vice President & MD, Global Business Services, Novo Nordisk
Bengaluru, April 08, 2024: Novo Nordisk Global Business Services (GBS) is revolutionizing employee wellness with the launch of two unique initiatives – The Flamingo Program and the WECare Flexible Benefits Program. These programs prioritize employee well-being at every stage of life, fostering a supportive and holistic work environment.
The Flamingo Programs includes extended maternity leave options, customized transportation, mentorship through the Amigo program, and a well-equipped mother’s room for continued breastfeeding. Similarly, the WECare program empowers employees to curate their well-being journey. Employees receive an annual INR 50,000 to choose from a wide range of benefits, including fitness memberships, work-from-home essentials, daycare, and medical equipment.
“At Novo Nordisk GBS, we prioritize employee well-being throughout their careers. We believe in fostering a supportive environment that empowers people to thrive, both personally and professionally. This includes prioritizing physical, mental, and emotional health. We continuously strive to create a safe and growth-oriented workplace that fuels a happy, healthy, and productive workforce. The Flamingo Program specifically addresses the unique needs of new mothers, a crucial life stage. We’re committed to supporting them in every way we can to ensure a smooth transition back to work”, said John Dawber, Corporate Vice President & MD, Global Business Services, Novo Nordisk.
This WECare program boasts a staggering 90% employee participation, contributing to a significant reduction in attrition rates. The company has seen a more than 50% drop, with rates going from 17-18% to below 8%.
Novo Nordisk GBS’s commitment to employee well-being sets a high bar for the pharmaceutical industry. These innovative programs demonstrate the company’s dedication to creating a thriving workplace culture that enriches the lives of its employees.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 57,100 people in 80 countries and markets its products in around 170 countries. Novo Nordisk Global Business Services (GBS) in India has had a significant footprint since 2010, committed to seamless high-quality solutions with a strong focus on talent incubation, digitalisation, and process excellence. With over 3,500 personnel the Bangalore based-hub partners with global colleagues across the Novo Nordisk pharma value chain to support drug development, manufacturing, commercial, and social business services.
